Related Experiment Video
Updated: May 8, 2026

09:44
Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
Published on: January 25, 2016
Advances in genetic diagnostics for hereditary hearing loss
Journal of Basic and Clinical Physiology and Pharmacology
|September 6, 2013
Summary
Genetic testing for hereditary hearing loss is advancing with new sequencing techniques. This review covers patient attitudes, modern mutation detection methods, and identified gene mutations in Israel.
Area of Science:
- Genetics
- Otolaryngology
- Medical Diagnostics
Background:
- Hereditary hearing loss accounts for over 50% of hearing impairment cases.
- Genetic mutations are the primary cause of hereditary hearing loss.
- Diagnostic methods are evolving from linkage analysis to next-generation sequencing.
Purpose of the Study:
- To review patient attitudes towards genetic testing for hearing loss.
- To discuss the latest mutation identification techniques.
- To compile a list of mutations in the Israeli Jewish hearing-impaired population.
Main Methods:
- Literature review of genetic testing attitudes.
- Analysis of next-generation sequencing advancements.
- Compilation of mutation data from Israeli Jewish families.
Main Results:
- Significant proportion of hearing loss is hereditary.
- Next-generation sequencing is transforming molecular diagnostics.
- Specific genetic mutations identified in the Israeli Jewish population.
Conclusions:
- Genetic testing is crucial for understanding hereditary hearing loss.
- Advancements in sequencing improve diagnostic accuracy.
- Understanding population-specific mutations aids in genetic counseling and treatment.
Related Concept Videos
Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
